Find the Perfect Plan for Your Investment Journey
Z
Latest price
52 Week Range
DKK380.20 - DKK972.00
Next Earnings Date
May 07 2025
Next Earnings Date
May 07 2025
Latest price
Market Cap | DKK30.04B |
EV | DKK21.38B |
Shares Outstanding | 71.37M |
Beta | 0.58 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | DKK947.92 |
P/E 2025E | 11.60x |
P/Revenue 2025E | 5.90x |
Revenue | -40.20% |
EPS | 11.90% |
Operating Cash Flow | 8.40% |
Free Cash Flow | 8.70% |
Revenue | 165.50% |
EPS | 5.80% |
Operating Cash Flow | -5.40% |
Free Cash Flow | -9.80% |
Gross Margin 2025E | 99.97% |
Net Profit Margin 2025E | 61.69% |
ROE 2025E | 28.21% |
ROCE 2024 | -21.13% |
DPS 2025E | DKK0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Z
Zealand Pharma A/S
ZEAL
Sector
Healthcare
Industry
Biotechnology
CEO
Steensberg, Adam
Employees
335
Website
www.zealandpharma.comIPO Date
2010-11-23
Headquarters
Sydmarken 11, Søborg, Capital Region of Denmark, 2860, Denmark
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved